Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II

摘要

AimsA non-invasive gene-expression profiling (GEP) test for rejection surveillance of heart transplant recipients originated in the USA. A European-based study, Cardiac Allograft Rejection Gene Expression Observational II Study (CARGO II), was conducted to further clinically validate the GEP test performance.